EDGAR Filing Documents for 0001437749-23-002087

Form 8-K - Current report:

SEC Accession No. 0001437749-23-002087

Filing Date

2023-01-31

Accepted

2023-01-31 09:05:23

Documents

Period of Report

2023-01-26

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	pbla20230130_8k.htm iXBRL	8-K	44331
2	EXHIBIT 4.1	ex_469630.htm	EX-4.1	118876
3	EXHIBIT 4.2	ex_469631.htm	EX-4.2	96517
4	EXHIBIT 4.3	ex_469632.htm	EX-4.3	131375
5	EXHIBIT 10.1	ex_469633.htm	EX-10.1	104877
6	EXHIBIT 10.2	ex_469634.htm	EX-10.2	204642
7	EXHIBIT 99.1	ex_469913.htm	EX-99.1	16479
12		ex_469913img001.jpg	GRAPHIC	5293
	Complete submission text file	0001437749-23-002087.txt		1024388

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	pbla-20230126.xsd	EX-101.SCH	3601
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	pbla-20230126_def.xml	EX-101.DEF	11532
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	pbla-20230126_lab.xml	EX-101.LAB	15414
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	pbla-20230126_pre.xml	EX-101.PRE	11688
14	EXTRACTED XBRL INSTANCE DOCUMENT	pbla20230130_8k_htm.xml	XML	2554

Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387

Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196

Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)